膜心脏病和结构性心脏干预的未来:为什么这么激动?
1Department of Cardiology, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.
Journal of personalized medicine
|September 26, 2025
概括
心脏病 (VHD) 影响人口老龄化,增加心血管风险. 诊断和治疗方面的进步提供了新的选择,强调个性化的患者护理,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 医疗成像医学成像
背景情况:
- 心脏膜疾病 (VHD) 在老年人群中越来越令人担忧,大大导致心血管疾病和死亡率.
- 非侵入性成像技术对于诊断VHD严重程度和通过形态和功能评估了解其潜在机制至关重要.
研究的目的:
- 审查目前诊断和治疗心脏膜疾病的进展.
- 强调个性化治疗决策在VHD管理中的重要性.
主要方法:
- 对VHD评估的非侵入性成像方法的审查.
- 分析当前的手术和导管干预策略.
- 在VHD治疗中讨论共享决策.
主要成果:
- 非侵入性成像已经改善了VHD诊断和机制阐明.
- 手术和导管干预提供了扩展的治疗选择,特别是对于老年人和高风险患者.
- 共享决策对于使治疗与患者的需求和期望保持一致至关重要.
结论:
- VHD管理需要整合先进的诊断和各种治疗方案.
- 个性化治疗规划,考虑患者特定因素,对于最佳的VHD护理至关重要.
- 未来的研究应该专注于开发更安全,更有效和更持久的VHD治疗方法.
相关概念视频
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Mitral Valve Prolapse II: Assessment and Management
425
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
425
Heart Valves
11.2K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
11.2K
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284


